<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="publisher-id">MEDI</journal-id>
      <journal-title-group>
        <journal-title>Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0025-7974</issn>
      <issn pub-type="epub">1536-5964</issn>
      <publisher>
        <publisher-name>Wolters Kluwer Health</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27057843</article-id>
      <article-id pub-id-type="pmc">4998759</article-id>
      <article-id pub-id-type="doi">10.1097/MD.0000000000003177</article-id>
      <article-id pub-id-type="art-access-id">03177</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>3400</subject>
        </subj-group>
        <subj-group>
          <subject>Research Article</subject>
          <subject>Clinical Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Diffuse Pulmonary Arteriovenous Fistulas With Pulmonary Arterial Hypertension</article-title>
        <subtitle>Case Report and Review</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>Rong</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gong</surname>
            <given-names>Su-Gang</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pudasaini</surname>
            <given-names>Bigyan</given-names>
          </name>
          <degrees>MS</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhao</surname>
            <given-names>Qin-Hua</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Lan</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>He</surname>
            <given-names>Jing</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Jin-Ming</given-names>
          </name>
          <degrees>PhD</degrees>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Fares.</surname>
            <given-names>Wassim</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff>From the Department of Cardio-Pulmonary Circulation, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China (RJ, S-GG, BP, Q-HZ, LW, JH, J-ML).</aff>
      <author-notes>
        <corresp>Correspondence: Jin-Ming Liu, Department of Cardio-Pulmonary Circulation, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433 China (e-mail: <email>jinmingliu2013@126.com</email>).</corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>4</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>08</day>
        <month>4</month>
        <year>2016</year>
      </pub-date>
      <volume>95</volume>
      <issue>14</issue>
      <elocation-id>e3177</elocation-id>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>11</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>12</day>
          <month>2</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>2</day>
          <month>3</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2016 Wolters Kluwer Health, Inc. All rights reserved.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nd/4.0">
          <license-p>This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nd/4.0">http://creativecommons.org/licenses/by-nd/4.0</ext-link></license-p>
        </license>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="medi-95-e3177.pdf"/>
      <abstract>
        <title>Abstract</title>
        <p>Pulmonary arteriovenous fistulas (PAVFs) are rare. Diffuse type PAVFs with pulmonary arterial hypertension (PAH) are even rarer and can elude anatomy imaging like a plain chest film or a computed tomography. The rapid blood flow that ensues due to lack of a capillary bed leads to various degrees of ischemia depending on the number and size of the PAVF. This is a case report of diffuse PAVF in a patient with PAH.</p>
        <p>This case report describes a patient with recurrent hemoptysis and chest pain. Systemic examination was unremarkable except for P2 attenuation on auscultation. Echocardiograghy showed confirmed pulmonary hypertension with mild dilation of right atrium and ventricle and a tricuspid regurgitation pressure gradient of 40 mm Hg and ruled out congenital heart diseases. Right heart catheterization revealed precapillary PAH with mean pulmonary arterial pressure of 88 mm Hg. Pulmonary angiography showed enlarged pulmonary arterial trunk and diffuse spiral tortuous pulmonary arterial branches indicting diffuse PAVFs. The patient was diagnosed as PAH and began treatment of 25&#x200A;mg tid of sildenafil.</p>
        <p>The case highlights a rare and unique presentation of PAH.</p>
      </abstract>
      <custom-meta-group>
        <custom-meta>
          <meta-name>OPEN-ACCESS</meta-name>
          <meta-value>TRUE</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Pulmonary arteriovenous fistulas (PAVFs) are abnormal pulmonary vascular structures that connect a pulmonary artery to a pulmonary vein, bypassing the normal capillary bed resulting in an intrapulmonary right-to-left shunt.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> PAVFs may be congenital or acquired with a majority being associated with hereditary hemorrhagic telangiectasia (HHT)<sup><xref rid="R2" ref-type="bibr">2</xref>&#x2013;<xref rid="R5" ref-type="bibr">5</xref></sup> which is caused by mutations in Endoglin (HHT 1) and activin receptor-like kinase (ALK1) (HHT 2).<sup><xref rid="R2" ref-type="bibr">2</xref></sup> Despite gene identification HHT remains a clinical diagnosis with clinical diagnostic criteria.<sup><xref rid="R6" ref-type="bibr">6</xref></sup> The majority of non-HHT-related PAVFs are idiopathic, but other etiologies include chest trauma,<sup><xref rid="R7" ref-type="bibr">7</xref></sup> Fanconi syndrome,<sup><xref rid="R8" ref-type="bibr">8</xref></sup> amyloidosis, and infections like schistosomiasis<sup><xref rid="R9" ref-type="bibr">9</xref></sup> and actinomycosis.<sup><xref rid="R7" ref-type="bibr">7</xref></sup> Clinically, PAVF is generally classified into 2 types: focal and diffuse. Compared with the local type, the diffuse type is rarer, more severe and therapy is limited. Reports on diffuse PAVF with pulmonary artery hypertension (PAH) are rare.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 28-year-old male presented with an 8-year history of recurrent hemoptysis and a year of chest pain. Systemic examination was unremarkable except for P2 attenuation on auscultation. He had no digital clubbing and no telangiectasia. Arterial blood gas showed partial pressure of arterial oxygen (PaO<sub>2</sub>) of 79 mm Hg and arterial oxygen saturation (SaO<sub>2</sub>) of 95.7% at room air. N-terminal pro-B-type natriuretic peptide (NT-proBNP): 33&#x200A;pg/mL (0&#x2013;125&#x200A;pg/mL). Electrocardiogram showed right axis derivation and echocardiography showed confirmed pulmonary hypertension with mild dilation of right atrium and ventricle and a tricuspid regurgitation pressure gradient (TPG) of 40 mm Hg. Congenital heart conditions including atrial septal defect, ventricular septal defect, and other intracardiac shunts were ruled out by echocardiography as well. There were no differences in SaO<sub>2</sub> of lower and upper extremities, which combing echocardiography may rule out patent ductus arteriosus. Connective tissue disease serology and thyroid function revealed negative. The patient had no history of chronic lung diseases. He has excellent pulmonary function [Forced inspiratory vital capacity (FVC)&#x200A;=&#x200A;4.04 L, FEV1 (pred %)&#x200A;=&#x200A;83.3, FEV1/FVC&#x200A;=&#x200A;0.78, and DLCO (pred %)&#x200A;=&#x200A;90.9&#x200A;mL/min per mm Hg]. A computed tomography pulmonary angiogram demonstrates wedge shadow near the pleura and along the airway distribution around with flake fuzzy shadow in the upper lobes (Figure <xref ref-type="fig" rid="F1">1</xref>) and excluded chronic thromboembolic disease. Right heart catheterization (RHC) revealed precapillary pulmonary arterial pressure (PAP) (right atrial pressure [RAP]: 6/&#x2212;1/1 mm Hg; right ventricle pressure [RVP]: 144/&#x2212;10/11 mm Hg; PAP: 139/59/88 mm Hg; pulmonary arterial wedge pressure: 17/4/8 mm Hg; cardiac output: 5.53 L/min; cardiac index: 3.48&#x200A;L/min per m<sup>2</sup>; pulmonary vascular resistance: 14.47 wood Units) without vasodilatory response to inhaled iloprost. Pulmonary angiography showed enlarged pulmonary artery trunk and diffuse spiral tortuous pulmonary arterial branches indicting diffuse PAVFs (Figure <xref ref-type="fig" rid="F2">2</xref>). Bronchography showed tortuous and dilated internal thoracic artery and bronchial artery and peripheral small vessels with diffuse PAVFs (Figure <xref ref-type="fig" rid="F3">3</xref>). He was diagnosed as PAH and began treatment of 25&#x200A;mg tid of sildenafil.</p>
      <fig id="F1" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Computed tomography pulmonary angiography. (A) Representative axial computed tomography image displayed with lung window settings demonstrates wedge shadow (arrow) near the pleura and along the airway distribution around with flake fuzzy shadow in the upper lobes. (B) Mediastina window.</p>
        </caption>
        <graphic xlink:href="medi-95-e3177-g001"/>
      </fig>
      <fig id="F2" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Pulmonary angiography showing diffuse pulmonary arteriovenous fistulas. Pulmonary angiography showing the absence of capillary blush and arteriovenous fistulas (arrow). (A) Main pulmonary artery angiography. (B) Left pulmonary artery angiography. (C) Right pulmonary artery angiography.</p>
        </caption>
        <graphic xlink:href="medi-95-e3177-g002"/>
      </fig>
      <fig id="F3" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Bronchography showing tortuous and dilated internal thoracic artery and bronchial artery (hollow arrow) and peripheral small vessels with diffuse distortion (diffuse pulmonary arteriovenous fistulas) (solid arrow) (both Figure 3A and Figure 3B).</p>
        </caption>
        <graphic xlink:href="medi-95-e3177-g003"/>
      </fig>
      <p>One year later, the patient was followed up by telephone, he told us his exercise tolerance had improved and had no symptoms of hemoptysis with treatment of sildenafil.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>We report a patient with diffuse PAVFs with severe PAH. PAVFs are rare, autopsy reports describing only 3 in 15,000 autopsies performed.<sup><xref rid="R10" ref-type="bibr">10</xref></sup> The approximate incidence of PAVF has been described to be 2 to 3 per 100,000<sup><xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R12" ref-type="bibr">12</xref></sup> with a male-to-female ratio of approximately 1:1.5 to 1.8.<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R13" ref-type="bibr">13</xref></sup> PAVFs may be single or multiple, unilateral or bilateral, simple or complex. Most solitary PAVFs are seen in the lower lobes, with the left lower lobe being the most common location.<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup> The majority of multiple PAVFs are also confined to the lower lobes, with the incidence of bilateral PAVFs ranging from 8% to 20%.<sup><xref rid="R7" ref-type="bibr">7</xref></sup> The abnormal segment between the pulmonary artery and the pulmonary vein is fragile and may rupture and bleed as the PAVF size increases, manifesting as hemoptysis or a hemothorax. Small subsets of patients have a more diffuse and severe type of PAVF that involves segmental pulmonary arteries. Diffuse PAVFs result in severe hypoxemia and are challenging to treat.</p>
      <p>Most PAVFs are hereditary, with about 90% occurring in patients with HHT.<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref></sup> The majority of non-HHT-related PAVFs are idiopathic, but other etiologies include chest trauma, Fanconi syndrome, amyloidosis, and infections such as schistosomiasis and actinomycosis. PAVFs also occur secondary to hepatopulmonary syndrome (HPS) or bidirectional cavopulmonary shunts (BCPS). The majority of patients with HHT have HHT1 because of mutations in endoglin (ENG) encoding endoglin<sup><xref rid="R16" ref-type="bibr">16</xref></sup> or HHT 2 because of mutations in ACVRL1 encoding ALK1.<sup><xref rid="R17" ref-type="bibr">17</xref></sup> PAH occurs almost exclusively in individuals with ACVRL1 mutation. The genes mutated in HHT encode proteins involved in the transforming growth factor &#x3B2; (TGF-&#x3B2;) superfamily signaling pathway.<sup><xref rid="R18" ref-type="bibr">18</xref></sup> The TGF-&#x3B2; pathway is important in regulating proliferation, differentiation, adhesion, and migration which are key processes in angiogenesis.</p>
      <p>This patient denied any history of hepatic diseases, epistaxis, telangiectasia, visceral lesions (except pulmonary malformations), and family history. According to mainstay of the Curacao criteria,<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R19" ref-type="bibr">19</xref></sup> the patient was unlikely to have HHT. Thus, although unusual the diagnosis was idiopathic PAH.</p>
      <p>In this case report, despite of high PAP by RHC, the RAP did not increase accordingly which may be due to compensated RV systolic and diastolic function to pulmonary vascular diseases. Early in PAH, the adaptive ventricular remodeling and preserved right ventricle reserve could adapt PAP and maintain RVP and RAP.<sup><xref rid="R20" ref-type="bibr">20</xref></sup> The good exercise tolerance and normal NT-proBNP level implied the patient had adaptive right ventricle reserve. It may explain why the patient did not have significant increased RAP.</p>
      <p>For this patient, a TPG by echocardiography was 40 mm Hg while systolic PAP [pulmonary arterial systolic pressure (PASP)] by RHC was 139 mm Hg. The TPG was estimated based on the modified Bernoulli equation and was then added to an estimate of RAP to obtain an estimate of PASP in the absence of right ventricular outflow obstruction<sup><xref rid="R21" ref-type="bibr">21</xref></sup>; however, Bernoulli method systematically underestimated or overestimated the PASP when actual PAP was too high or too low.<sup><xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref></sup> Echocardiography has its inherent limitation; echocardiography may frequently be inaccurate in estimating PAP in patients being evaluated for PH.</p>
    </sec>
    <sec sec-type="conclusion">
      <title>CONCLUSIONS</title>
      <p>The case highlights a rare and unique presentation of PAH. Most cases of PAVF can remain asymptomatic until the third or fourth decade of life. Moreover, the shunting may facilitate passage of emboli into the cerebral circulation thereby being implicated in various other pathologies. Although prognosis is poor, such patients would benefit tremendously by early detection and appropriate management.</p>
    </sec>
    <sec>
      <title>CONSENT</title>
      <p>The patient signed informed consent for the publication of this case report and any accompanying images. Ethical approval of this study was obtained by the ethics committee of Shanghai Pulmonary Hospital.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="abbr">
        <p>Abbreviations: ALK1 = activin receptor-like kinase, BCPS = bidirectional cavopulmonary shunts, HHT = hereditary hemorrhagic telangiectasia, HPS = hepatopulmonary syndrome, NT-proBNP = N-terminal pro-B-type natriuretic peptide, PAH = pulmonary artery hypertension, PAVF = pulmonary arteriovenous fistulas, RAP = right atrial pressure, RHC = right heart catheterization, RVP = right ventricle pressure, TGF-&#x3B2; = transforming growth factor &#x3B2;, TPG = tricuspid regurgitation pressure gradient.</p>
      </fn>
      <fn fn-type="equal">
        <p>RJ and S-GG contributed equally to the manuscript.</p>
      </fn>
      <fn fn-type="COI-statement">
        <p>The authors have no funding and conflicts of interest to disclose.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="R1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname><given-names>KL</given-names></name><name><surname>Prakash</surname><given-names>UB</given-names></name><name><surname>Stanson</surname><given-names>AW</given-names></name></person-group>
<article-title>Pulmonary arteriovenous fistulas: Mayo Clinic experience, 1982&#x2013;1997</article-title>. <source><italic>Mayo Clin Proc</italic></source>
<year>1999</year>; <volume>74</volume>:<fpage>671</fpage>&#x2013;<lpage>680</lpage>.<pub-id pub-id-type="pmid">10405695</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shovlin</surname><given-names>CL</given-names></name><name><surname>Letarte</surname><given-names>M</given-names></name></person-group>
<article-title>Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms</article-title>. <source><italic>Thorax</italic></source>
<year>1999</year>; <volume>54</volume>:<fpage>714</fpage>&#x2013;<lpage>729</lpage>.<pub-id pub-id-type="pmid">10413726</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dines</surname><given-names>DE</given-names></name><name><surname>Arms</surname><given-names>RA</given-names></name><name><surname>Bernatz</surname><given-names>PE</given-names></name><etal/></person-group>
<article-title>Pulmonary arteriovenous fistulas</article-title>. <source><italic>Mayo Clin Proc</italic></source>
<year>1974</year>; <volume>49</volume>:<fpage>460</fpage>&#x2013;<lpage>465</lpage>.<pub-id pub-id-type="pmid">4834927</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dines</surname><given-names>DE</given-names></name><name><surname>Seward</surname><given-names>JB</given-names></name><name><surname>Bernatz</surname><given-names>PE</given-names></name></person-group>
<article-title>Pulmonary arteriovenous fistulas</article-title>. <source><italic>Mayo Clin Proc</italic></source>
<year>1983</year>; <volume>58</volume>:<fpage>176</fpage>&#x2013;<lpage>181</lpage>.<pub-id pub-id-type="pmid">6219255</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gossage</surname><given-names>JR</given-names></name><name><surname>Kanj</surname><given-names>G</given-names></name></person-group>
<article-title>Pulmonary arteriovenous malformations. A state of the art review</article-title>. <source><italic>Am J Respir Crit Care Med</italic></source>
<year>1998</year>; <volume>158</volume>:<fpage>643</fpage>&#x2013;<lpage>661</lpage>.<pub-id pub-id-type="pmid">9700146</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guttmacher</surname><given-names>AE</given-names></name><name><surname>Marchuk</surname><given-names>DA</given-names></name><name><surname>White</surname><given-names>RI</given-names><suffix>Jr</suffix></name></person-group>
<article-title>Hereditary hemorrhagic telangiectasia</article-title>. <source><italic>N Engl J Med</italic></source>
<year>1995</year>; <volume>333</volume>:<fpage>918</fpage>&#x2013;<lpage>924</lpage>.<pub-id pub-id-type="pmid">7666879</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prager</surname><given-names>RL</given-names></name><name><surname>Laws</surname><given-names>KH</given-names></name><name><surname>Bender</surname><given-names>HW</given-names><suffix>Jr</suffix></name></person-group>
<article-title>Arteriovenous fistula of the lung</article-title>. <source><italic>Ann Thorac Surg</italic></source>
<year>1983</year>; <volume>36</volume>:<fpage>231</fpage>&#x2013;<lpage>239</lpage>.<pub-id pub-id-type="pmid">6349562</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taxman</surname><given-names>RM</given-names></name><name><surname>Halloran</surname><given-names>MJ</given-names></name><name><surname>Parker</surname><given-names>BM</given-names></name></person-group>
<article-title>Multiple pulmonary arteriovenous malformations in association with Fanconi's syndrome</article-title>. <source><italic>Chest</italic></source>
<year>1973</year>; <volume>64</volume>:<fpage>118</fpage>&#x2013;<lpage>120</lpage>.<pub-id pub-id-type="pmid">4717446</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Faria</surname><given-names>JL</given-names></name><name><surname>Czapski</surname><given-names>J</given-names></name><name><surname>Leite</surname><given-names>MO</given-names></name><etal/></person-group>
<article-title>Cyanosis in Manson's schistosomiasis; role of pulmonary schistosomatic arteriovenous fistulas</article-title>. <source><italic>Am Heart J</italic></source>
<year>1957</year>; <volume>54</volume>:<fpage>196</fpage>&#x2013;<lpage>204</lpage>.<pub-id pub-id-type="pmid">13444184</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sloan</surname><given-names>RD</given-names></name><name><surname>Cooley</surname><given-names>RN</given-names></name></person-group>
<article-title>Congenital pulmonary arteriovenous aneurysm</article-title>. <source><italic>Am J Roentgenol Radium Ther Nucl Med</italic></source>
<year>1953</year>; <volume>70</volume>:<fpage>183</fpage>&#x2013;<lpage>210</lpage>.</mixed-citation>
      </ref>
      <ref id="R11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vase</surname><given-names>P</given-names></name><name><surname>Holm</surname><given-names>M</given-names></name><name><surname>Arendrup</surname><given-names>H</given-names></name></person-group>
<article-title>Pulmonary arteriovenous fistulas in hereditary hemorrhagic telangiectasia</article-title>. <source><italic>Acta Med Scand</italic></source>
<year>1985</year>; <volume>218</volume>:<fpage>105</fpage>&#x2013;<lpage>109</lpage>.<pub-id pub-id-type="pmid">4050544</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodgson</surname><given-names>CH</given-names></name><name><surname>Kaye</surname><given-names>RL</given-names></name></person-group>
<article-title>Pulmonary arteriovenous fistula and hereditary hemorrhagic telangiectasia: a review and report of 35 cases of fistula</article-title>. <source><italic>Dis Chest</italic></source>
<year>1963</year>; <volume>43</volume>:<fpage>449</fpage>&#x2013;<lpage>455</lpage>.<pub-id pub-id-type="pmid">13963797</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdalla</surname><given-names>SA</given-names></name><name><surname>Letarte</surname><given-names>M</given-names></name></person-group>
<article-title>Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease</article-title>. <source><italic>J Med Genet</italic></source>
<year>2006</year>; <volume>43</volume>:<fpage>97</fpage>&#x2013;<lpage>110</lpage>.<pub-id pub-id-type="pmid">15879500</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faughnan</surname><given-names>ME</given-names></name><name><surname>Granton</surname><given-names>JT</given-names></name><name><surname>Young</surname><given-names>LH</given-names></name></person-group>
<article-title>The pulmonary vascular complications of hereditary haemorrhagic telangiectasia</article-title>. <source><italic>Eur Respir J</italic></source>
<year>2009</year>; <volume>33</volume>:<fpage>1186</fpage>&#x2013;<lpage>1194</lpage>.<pub-id pub-id-type="pmid">19407052</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cartin-Ceba</surname><given-names>R</given-names></name><name><surname>Swanson</surname><given-names>KL</given-names></name><name><surname>Krowka</surname><given-names>MJ</given-names></name></person-group>
<article-title>Pulmonary arteriovenous malformations</article-title>. <source><italic>Chest</italic></source>
<year>2013</year>; <volume>144</volume>:<fpage>1033</fpage>&#x2013;<lpage>1044</lpage>.<pub-id pub-id-type="pmid">24008954</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAllister</surname><given-names>KA</given-names></name><name><surname>Grogg</surname><given-names>KM</given-names></name><name><surname>Johnson</surname><given-names>DW</given-names></name><etal/></person-group>
<article-title>Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1</article-title>. <source><italic>Nat Genet</italic></source>
<year>1994</year>; <volume>8</volume>:<fpage>345</fpage>&#x2013;<lpage>351</lpage>.<pub-id pub-id-type="pmid">7894484</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>DW</given-names></name><name><surname>Berg</surname><given-names>JN</given-names></name><name><surname>Baldwin</surname><given-names>MA</given-names></name><etal/></person-group>
<article-title>Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2</article-title>. <source><italic>Nat Genet</italic></source>
<year>1996</year>; <volume>13</volume>:<fpage>189</fpage>&#x2013;<lpage>195</lpage>.<pub-id pub-id-type="pmid">8640225</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname><given-names>J</given-names></name><name><surname>Bayrak-Toydemir</surname><given-names>P</given-names></name><name><surname>Pyeritz</surname><given-names>RE</given-names></name></person-group>
<article-title>Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis</article-title>. <source><italic>Genet Med</italic></source>
<year>2011</year>; <volume>13</volume>:<fpage>607</fpage>&#x2013;<lpage>616</lpage>.<pub-id pub-id-type="pmid">21546842</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shovlin</surname><given-names>CL</given-names></name><name><surname>Guttmacher</surname><given-names>AE</given-names></name><name><surname>Buscarini</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)</article-title>. <source><italic>Am J Med Genet</italic></source>
<year>2000</year>; <volume>91</volume>:<fpage>66</fpage>&#x2013;<lpage>67</lpage>.<pub-id pub-id-type="pmid">10751092</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vonk-Noordegraaf</surname><given-names>A</given-names></name><name><surname>Haddad</surname><given-names>F</given-names></name><name><surname>Chin</surname><given-names>KM</given-names></name><etal/></person-group>
<article-title>Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology</article-title>. <source><italic>J Am Coll Cardiol</italic></source>
<year>2013</year>; <volume>62</volume>:<fpage>D22</fpage>&#x2013;<lpage>D33</lpage>.<pub-id pub-id-type="pmid">24355638</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudski</surname><given-names>LG</given-names></name><name><surname>Lai</surname><given-names>WW</given-names></name><name><surname>Afilalo</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography</article-title>. <source><italic>J Am Soc Echocardiogr</italic></source>
<year>2010</year>; <volume>23</volume>:<fpage>685</fpage>&#x2013;<lpage>713</lpage>.<comment>quiz 86-8</comment>.<pub-id pub-id-type="pmid">20620859</pub-id></mixed-citation>
      </ref>
      <ref id="R22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falahatpisheh</surname><given-names>A</given-names></name><name><surname>Rickers</surname><given-names>C</given-names></name><name><surname>Gabbert</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Simplified Bernoulli's method significantly underestimates pulmonary transvalvular pressure drop</article-title>. <source><italic>J Magn Reson Imaging</italic></source>
<year>2015</year>.</mixed-citation>
      </ref>
      <ref id="R23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>MR</given-names></name><name><surname>Forfia</surname><given-names>PR</given-names></name><name><surname>Chamera</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension</article-title>. <source><italic>Am J Respir Crit Care Med</italic></source>
<year>2009</year>; <volume>179</volume>:<fpage>615</fpage>&#x2013;<lpage>621</lpage>.<pub-id pub-id-type="pmid">19164700</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
